Erschienen in:
29.11.2016 | Editorial
“Slow and steady wins the race”: the importance of perseverance in the management of oncogenic osteomalacia
verfasst von:
Maria Manara, Luigi Sinigaglia
Erschienen in:
Endocrine
|
Ausgabe 1/2017
Einloggen, um Zugang zu erhalten
Excerpt
Despite the recent advances in understanding the pathogenesis of oncogenic osteomalacia, a rare paraneoplastic syndrome related to an excessive production of the phosphaturic hormone fibroblast growth factor 23 (FGF-23) by the tumor, the clinical diagnosis of this entity is still to be considered a clinical challenge, with an usual delay in the identification and treatment of affected patients that may lead to severe consequences for the individual’s quality of life. …